Common use of Development and Commercialization Activities Clause in Contracts

Development and Commercialization Activities. The parties shall cooperate fully in connection with the development and commercialization of the Anti-IgE Product. Tanox shall assume primary responsibility in coordination with the Steering Committee (as defined in the D & L Agreement) for pursuing any additional development activities in the EA Countries which may be necessary or beneficial in connection with obtaining product registration and marketing approval in such countries. Ciba shall have the right to market and sell the Anti-IgE Product following marketing approval. Tanox shall have the right to supply product to the EA Countries at cost from its pilot facility in Houston, Texas, and/or from a facility owned and operated by the EA Company. To the extent Tanox is unable to supply all the product which may be required for the EA Countries, such product also may be purchased from Genentech or supplied by Ciba, as applicable.